Please login to the form below

Not currently logged in
Email:
Password:

Flucelvax

This page shows the latest Flucelvax news and features for those working in and with pharma, biotech and healthcare.

GSK gets OK for second quadrivalent flu vaccine in US

GSK gets OK for second quadrivalent flu vaccine in US

Instead, the Swiss firm has focused its R&D investment on switching from egg-based to cell culture-based production, securing approval for its FluCelVax product in November 2012.

Latest news

  • GSK's four-strain flu vaccine debuts in the US GSK's four-strain flu vaccine debuts in the US

    Novartis has concentrated on developing cell-manufactured flu vaccines, having recently won approval in the US for its Flucelvax trivalent candidate, and is arguably lagging in the quadrivalent stakes.

  • Novartis gets US approval for Flucelvax flu jab made in cells Novartis gets US approval for Flucelvax flu jab made in cells

    It added that, unlike conventional flu vaccines, Flucelvax does not contain preservative such as thimerosal. ... Flucelvax will be produced in Holly Springs once the facility is ready for full-scale commercial production," said Novartis in a statement.

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics